Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_243110086

Sanofi and Lexicon’s Zynquista scores EU approval for type 1 diabetes patients

April 29, 2019
Sales and Marketing Lexicon, Sanofi, Type 1 diabetes, Zynquista, diabetes, pharma

The European Commission has authorised the use of Sanofi and Lexicon’s Zynquista (sotagliflozin) in Europe in the treatment of specific …

News

Gilead subsidiary Kite Pharma to open CAR-T manufacturing facility in Maryland

April 29, 2019
Manufacturing and Production, Sales and Marketing CAR-T, Gilead, Manufacturing Facility, Maryland, kite pharma

Gilead Sciences subsidiary Kite Pharma has announced plans to open a new CAR-T manufacturing facility in Frederick County, Maryland (US). …

News
credit_-_daniel_leal-olivas-afp

AZ and MSD’s Lynparza secures CHMP nod in first-line BRCA-mutated ovarian cancer

April 29, 2019
Sales and Marketing AstraZeneca, CHMP, Cancer, MSD, lynparza, ovarian cancer, pharma

AstraZeneca and MSD’s Lynparza (olaparib) has received a positive opinion from the EMA’s Committee for Medicinal Products for Human Use …

News

India hits back at claims they are leading source of counterfeit drugs

April 29, 2019
Sales and Marketing

India has rejected claims that they, along with China, are the chief source of counterfeit medicines around the world. In …

News
opioid_pills

Opioids to be labelled with addiction warning in UK

April 29, 2019
Sales and Marketing

All opioid medicines sold in the UK will be labelled with a warning as to the potential for addiction, Health …

News
gilead-sciences

Gilead’s selonsertib crashes at Phase 3 in NASH

April 26, 2019
Medical Communications, Research and Development, Sales and Marketing Gilead, nash, pharma, selonsertib

Gilead has broken the news that its apoptosis signal-regulating kinase 1 (ASK1) inhibitor selonsertib failed to meet its primary endpoint …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

April 26, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aduro Biotech, Cancer, GSK, ICR, J&J, JJ, Novartis, Sandoz, pharma

The Institute for Cancer Research (ICR) called for new measures to increase the speed with which patients in the UK …

News
richard_saynor

Senior GSK exec Richard Saynor revealed as new Sandoz CEO

April 26, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor …

Appointment
lilly_building_with_american_flag_web

Eli Lilly to withdraw Lartruvo from market in soft tissue sarcoma following Phase 3 failure

April 26, 2019
Medical Communications, Sales and Marketing Cancer, Eli Lilly, Lartruvo, pharma, soft tissue sarcoma

Eli Lilly has revealed it is to withdraw its platelet-derived growth factor receptor alpha (PDGFR-α) blocking antibody Lartruvo (olaratumab) from …

News
bug_plants_insect_leaf_nature_macrophotography_naturephotography_macro-1046343

Funding to fight malaria falls $2 billion short of WHO target, study shows

April 26, 2019
Medical Communications WHO, developing countires, funding, health economics, infectious diseases, malaria

Global spending on the fight against malaria has stalled, falling $2 billion short of World Health Organization (WHO) targets, according …

News
cancer-cells-541954_960_720

Researchers find Achilles’ heel protein in leukaemia

April 26, 2019
Medical Communications AML, Edinburgh, Protein, YTHDF2, blood cancer, drug targets, leukaemia

An international team of researchers have identified an “Achilles’ heel” protein that could lead to the development of novel treatments …

News
dw-anzcxqaqavhl

FDA approves Beximco’s generic version of MSD’s allergy drug Periactin

April 25, 2019
Sales and Marketing FDA, MSD, Periactin, allergy, generics, pharma

Bangladesh-based Beximco Pharma is celebrating following the decision from the FDA to approve its generic version of MSD’s antihistamine therapy …

News

Pharmacists should review care homes residents’ medicine regimens to reduce polypharmacy

April 25, 2019
Medical Communications care homes, older people, pharmacists, pharmacy, polypharmacy

Pharmacists should review older people’s medicines regimens in order to reduce inappropriate polypharmacy, according to the Royal Pharmaceutical Society (RPS). …

News

ICR calls for faster access to innovative cancer drugs

April 25, 2019
Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, R&D, access, cancer drugs, incentives, innovation, oncology, pricing

The Institute of Cancer Research (ICR) has called for faster access to innovative cancer drugs in the UK. The call …

News

Interactions with the Agencies During Drug Development

April 25, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, NDA, drug development

 NDA would like to invite you to join  Professor Steffen Thirstrup, Director NDA Advisory Board, formerly Division Head at the Danish Medicines …

News
Press release
richard_saynor

Senior GSK exec Richard Saynor revealed as new Sandoz CEO

April 25, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sandoz, appointment, pharma

Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor …

News
blood-1813410_960_720

Heart drugs show promise in stroke and dementia

April 25, 2019
Research and Development angina, cilostazol, dementia, heart drugs, isosorbide mononitrate, stroke

Drugs for heart disease and angina have shown promise as preventative treatments for stroke and dementia, according to scientists from …

News

Pharma boosts lobby spending in first quarter of 2019

April 24, 2019
Research and Development PhRMA, Trump, USA, congress, lobbying, lobbyists, pharma

The Pharmaceutical Research and Manufacturers of America (PhRMA) trade lobbyists have spent near record levels on lobbying in the first …

News

Working Life: Dr Todd Hobbs, Vice President and Chief Medical Officer, Novo Nordisk

April 24, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Working Life, feature, pharma

Novo Nordisk’s VP and CMO discusses his leap from family medicine into the pharma industry, his biggest achievements, and how …

Feature
abbvie_0

AbbVie’s Skyrizi snatches up FDA approval in moderate to severe plaque psoriasis

April 24, 2019
Research and Development, Sales and Marketing AbbVie, FDA, Skyrizi, US, pharma, psoriasis

AbbVie has revealed that its interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab-rzaa) has received marketing authorisation in the US from the FDA …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026